A clinical case report: stroke in a young patient with systemic lupus erythematosus on the background of secondary antiphospholipid syndrome





antiphospholipid syndrome, ischemic stroke, antiphospholipid antibodies


The article describes a clinical case report of a young patient with ischemic stroke on the background of antiphospholipid syndrome (APLS). The uniqueness of this case lies in the complex diagnostic search that we performed. On admission, the patient had general cerebral, general infectious and focal syndromes. We suspected encephalitis due to the peculiarities of the onset of the disease and the results of computed tomography. However, after the results of lumbar puncture, the diagnosis of encephalitis required careful differential diagnosis. We performed an extensive diagnostic search. Based on clinical-laboratory, instrumental and immunological data the patient had the following final diagnosis: “Ischemic cardioembolic stroke in the right middle cerebral artery pool (15.10.17) (ICD 11: 8B11.5). Acute period with left pyramidal reflex insufficiency and changes in magnetic resonance imaging. Systemic lupus erythematous (ICD 11: 4A40.0), subacute course, activity II, with the lesion of skin (transient erythematous rash), kidneys (proteinuria, transient impaired renal function), lungs (bilateral pleurisy with immunological disorders). Secondary APLS (ICD 11: 4A45) (Acute iliofemoral thrombosis, May 2017; chronic thrombosis of the inferior vena cava, iliac veins, positive IgG to cardiolipin, beta 2 glycoproteins). Thus, we have to link thrombotic complications in young patients with APLS and to examine the patients for antiphospholipid antibody presence.


Shkrobot S, Sokhor N, Milevska-Vovchuk L, Yasnii O, Shkrobot L. [Clinical and hemodynamic features of the course of the acute period of ischemic hemodynamic stroke]. Georgian medical news. 2017;2(263):35-44. Russian.

Chaturvedi S, McCrae KR. Diagnosis and management of the antiphospholipid syndrome. Blood Rev. 2017 Nov;31(6):406-17. PMID: 28784423. doi: https://doi.org/10.1016/j.blre.2017.07.006

Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018;378:2010-21. doi: https://doi.org/10.1056/NEJMra1705454

Krytskyy T, Pasyechko N, Yarema N, Naumova L, Mazur l. Influence of age-related androgen defi-ciency on the risk factors for cardiovascular diseases in men with hypothyroidism. Georgian medical news. 2020;298:105-9. doi: https://doi.org/10.1530/endoabs.73.EP219

Lin Z, Liu Y, Chen L, Cao S, Huang Y, Yang X, et al. Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets. J.Sci China Life Sci. 2021 Jan 19. PMID: 33481164.

doi: https://doi.org/10.1007/s11427-020-1840-1

Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, et al. PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group. Am J Obstet Gynecol. 2017 May; 216(5):525.e1-e12. PMID: 28153662. doi: https://doi.org/10.1016/j.ajog.2017.01.026

Sayar Z, Moll R, Isenberg D, Cohen. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management. H.Thromb Res. 2021 Feb;198:213-21. PMID: 33485122. doi: https://doi.org/10.1016/j.thromres.2020.10.010

Schreiber K, Hunt Managing antiphospholipid syndrome in pregnancy. BJ.Thromb Res. 2019 Sep;181(Suppl 1):S41-S46. PMID: 31477227 Review. doi: https://doi.org/10.1016/S0049-3848(19)30366-4

Shkrobot SI, Sokhor NR, Milevska-Vovchuk LS, Krynytska IYa, Marushchak MI, Shkrobot LV, Yas-nii OR. Clinical neurological characteristics of ischemic stroke subtypes in acute phase. Zaporozhye medical journal. 2018;20(1):41-46. doi: https://doi.org/10.14739/2310-1210

Stack Christopher A, Cole John W, Ischemic stroke in young adults Curr Opin Cardiol. 2018 Nov;33(6):594-604. doi: https://doi.org/10.1097/HCO.0000000000000564




How to Cite

Shkrobot S, Milevska-Vovchuk L, Duve K, Naumova L, Budarna O. A clinical case report: stroke in a young patient with systemic lupus erythematosus on the background of secondary antiphospholipid syndrome. Med. perspekt. [Internet]. 2022Dec.29 [cited 2023Jun.10];27(4):259-63. Available from: http://journals.uran.ua/index.php/2307-0404/article/view/271243